Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Agenus Inc AGEN

Healthcare Biotechnology
Agenus Inc. is an immuno-oncology (I-O) company targeting cancer and infectious diseases with a pipeline of immunological agents. It is specialized in developing therapies to activate the body's immune system against cancer and infections. Its pipeline includes immune-modulatory antibodies, adoptive cell therapies (via MiNK Therapeutics, Inc.), and vaccine adjuvants (via SaponiQx, Inc.). Its... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:AGEN)

Agenus Reports Third Quarter 2024 Financial Results and Strategic Advancements in BOT/BAL Development

Business Wire 9 days ago

Agenus to Present Compelling Data on Botensilimab and AGEN1721 at SITC 2024

Business Wire November 7, 2024

November 5, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against - AGEN

Accesswire November 5, 2024

AGEN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Agenus Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Newsfile November 5, 2024

Shareholders that lost money on Agenus Inc. (AGEN) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More

Accesswire November 5, 2024

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Agenus

Newsfile November 5, 2024

Agenus to Provide Third Quarter 2024 Financial Report and Corporate Update

Business Wire November 5, 2024

Agenus Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before November 5, 2024 to Discuss Your Rights - AGEN

Accesswire November 5, 2024

FINAL AGEN DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Agenus Inc. Investors to Join the Class Action Lawsuit!

Accesswire November 5, 2024
View More News ››

Opinion & Analysis (NDAQ:AGEN)

Seven biotech names on the upswing: 2016 small-cap biotech watchlist update

The Life Sciences Report March 11, 2016
View More Opinion ››

Bullboard Posts (NDAQ:AGEN)

Agenus (AGEN) Q3 2024 Earnings Call Transcript

BREAKING NEWS: $AGEN Agenus (AGEN) Q3 2024 Earnings Call Transcript2024-11-12 12:15:14 ET Image source: The Motley Fool. Agenus (NASDAQ:...
whytestocks - 8 days ago

Gainey McKenna & Egleston Announces A Class&#xA0;Action Laws

Just In: $AGEN Gainey McKenna & Egleston Announces A Class&#xA0;Action Lawsuit Has Been Filed Against Agenus, Inc. (AGEN)NEW...
whytestocks - September 9, 2024

Using technical analysis for this one.

You can see that the law firms are busy with lawsuits for all of the people who paid big bucks for this stock and are way out of the...
coolfooldumbguy - August 2, 2024

It is off the bottom for the year.

Which is a good sign for this stock,plus it is in a good spot with cancer resrarch.
coolfooldumbguy - August 2, 2024

This stock is still cheap.

It should be back up over $10 per share,not by the end of this month,but probably by the end of this year,so glta.
coolfooldumbguy - August 2, 2024

Agenus Inc. (NASDAQ:AGEN): Unlocking the Potential of Immuno

http://beyondspx.com/2024/07/31/agenus-inc-nasdaqagen-unlocking-the-potential-of-immunotherapy-combinations/
MikeTester - August 2, 2024
View more Bullboard ››

Coelacanth Energy Inc.

Coelacanth Energy Inc.

Coelacanth Energy Inc. is a Montney-focused oil and natural gas exploration and development company, with lands located in ...
View More »